From Justin Andrew Marsh, CEO of Arthur Andrew Medical
To all of our valued customer and clientele:
With great regret we are writing to inform you that we are discontinuing the manufacture of our raw nattokinase product, Nattobiotic. My team and I at Arthur Andrew Medical take great pride in offering unique and efficacious products to the market. Unfortunately, with unique and forward-thinking products comes risk, as there are typically not readily available materials that can replace such products in the event of shortages. Nattobiotic possesses unique qualities that cannot simply be duplicated by combining various available components due to the fact that it is a raw food sourced extract (believe me, we tried!).
As you may or may not know, we have endured a lengthy shortage of Nattobiotic over the past several months while we worked to procure the base material used in the formula. Because the product is a food sourced extract, there are always variables in nature that can impact the manufacturing process and the resulting product. These variables are what caused the significant delays in production of the product. Unfortunately, our efforts have only resulted in a material that continues to not meet our stringent demands for activity levels and quality that we set when we released the product in 2011.
Due to these inconsistencies delaying our production process, we have decided that it is in the best interest for us and our clientele to forego manufacturing and promoting the product as we cannot guarantee a consistent stock, and we likely would not have additional inventory for months. We are still holding out hope that we can refine the process that provided us the unique material we brought to the market in our previous batches… but until then, we will be replacing the formula with a nattokinase product that we can stand behind, which will also be a great value to our clients.
With that said, I am pleased to announce the arrival of Nattovena (Na-toe-vay-na), a pure nattokinase which will boast 4,000 fibrinolytic units per capsule, making it the industry’s strongest and most potent nattokinase product available. What makes the release of Nattovena even more exciting is that we have been able to competitively price this product at an unprecedentedly low price. Nattovena will be more affordable than many of the leading brands that contain half, or even a fourth, of the activity of Nattovena.
Nattovena will be offered in 30, 90, and 180 capsule count bottles. For information on pricing and opening order discounts, please contact us at 800-448-5015 or click here to pre-order now. We look forward to the rollout of this new and exciting product which we anticipate to be ready for release by September 20th.
I personally thank you all for your loyalty and patronage to Arthur Andrew Medical. My staff and I look forward to continue to serve you with only the best in quality and efficacious products.
Thank you sincerely,
Justin A Marsh